SIMEONE, PAOLA GIUSTINA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.908
AS - Asia 1.080
EU - Europa 998
SA - Sud America 178
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.199
Nazione #
US - Stati Uniti d'America 1.864
SG - Singapore 496
IT - Italia 287
CN - Cina 250
IE - Irlanda 155
RU - Federazione Russa 151
BR - Brasile 130
VN - Vietnam 120
SE - Svezia 114
GB - Regno Unito 72
DE - Germania 48
TR - Turchia 48
UA - Ucraina 46
HK - Hong Kong 44
BD - Bangladesh 42
FR - Francia 32
FI - Finlandia 25
CA - Canada 22
AR - Argentina 21
MX - Messico 19
IN - India 15
JP - Giappone 14
NL - Olanda 11
PL - Polonia 11
ZA - Sudafrica 10
AT - Austria 8
ES - Italia 8
KR - Corea 8
MA - Marocco 8
BE - Belgio 7
ID - Indonesia 7
IQ - Iraq 7
CL - Cile 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
EC - Ecuador 5
LT - Lituania 5
VE - Venezuela 5
PY - Paraguay 4
TH - Thailandia 4
CO - Colombia 3
HU - Ungheria 3
NG - Nigeria 3
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
EG - Egitto 2
KE - Kenya 2
LK - Sri Lanka 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.199
Città #
Singapore 380
Ashburn 241
San Jose 237
Chandler 219
Dublin 154
Dallas 137
Jacksonville 73
Beijing 66
Council Bluffs 65
Princeton 58
Los Angeles 55
Ann Arbor 50
The Dalles 50
Ho Chi Minh City 46
Hong Kong 42
Pescara 42
New York 41
Santa Clara 33
Hanoi 32
Chieti 30
Dearborn 26
Izmir 25
Altamura 24
Southend 24
Boardman 23
Wilmington 23
Moscow 19
Rome 17
Buffalo 16
Redondo Beach 14
Tokyo 14
Washington 14
Nanjing 13
Shenyang 12
Stockholm 12
Denver 11
Nuremberg 11
Frankfurt am Main 10
Helsinki 10
Mexico City 10
Milan 10
Montreal 10
Munich 10
Orem 10
São Paulo 10
Cambridge 9
Hefei 9
Phoenix 9
Johannesburg 8
St Louis 8
Torre de' Passeri 8
Warsaw 8
Brussels 7
Houston 7
Ottawa 7
Seoul 7
Ankara 6
Chicago 6
Falls Church 6
Lappeenranta 6
London 6
Naples 6
Poplar 6
Vienna 6
Woodbridge 6
Amsterdam 5
Brooklyn 5
Da Nang 5
Hebei 5
Terni 5
Tongling 5
Atlanta 4
Boston 4
Brno 4
Caserta 4
Chennai 4
Manchester 4
Nanchang 4
Rio de Janeiro 4
Shanghai 4
Asunción 3
Baghdad 3
Changsha 3
Guangzhou 3
Jundiaí 3
Kunming 3
Mumbai 3
Norwalk 3
Querétaro 3
Rabat 3
Roccamontepiano 3
Santiago 3
Seattle 3
Venice 3
Wuhan 3
Ananindeua 2
Ancona 2
Baoding 2
Bialystok 2
Bismarck 2
Totale 2.691
Nome #
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 154
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 141
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 141
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 141
Platelets and Diabetes 138
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 135
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 134
Coagulation and infective endocarditis: sooner or later 132
Platelets and diabetes mellitus 131
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 129
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 129
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 129
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 129
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 124
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 122
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 117
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 116
The left atrial appendage: from embryology to prevention of thromboembolism 115
Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss 108
Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes 107
Aspirin in primary prevention: the triumph of clinical judgement over complex equations 106
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 105
Endogenous PCSK9 may influence circulating CD45NEG/CD34BRIGHT and CD45NEG/CD34BRIGHT/CD146NEG cells in patients with type 2 Diabetes Mellitus 103
Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. 103
Kinetics of Circulating Extracellular Vesicles Over the 24-Hour Dosing Interval After Low-Dose Aspirin Administration in Patients at Cardiovascular Risk 102
The Role of Platelets in Diabetes Mellitus 100
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes 98
An atypical etiology of ARDS: the importance of a careful eye in the evaluation. 98
Preeclampsia: Insights into pathophysiological mechanisms and preventive strategies 95
Addressing unmet needs in the use of SGLT2 inhibitors in critical and acute care setting 93
Could ischemic colitis be the first manifestation of COVID-19? A case report 85
Early prescription of SGLT2i for acute patient care: from current evidence to future directions 84
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 83
Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus 79
Effective response to treatment in patient with verisimilar antibody-negative paraneoplastic limbic encephalitis: a case report. 73
Sex-Specific Association of Endogenous PCSK9 With Memory Function in Elderly Subjects at High Cardiovascular Risk 70
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 68
Neurological features of COVID-19 infection: A case series of geriatric patients 65
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review 63
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis 62
Non-dipper blood pressure pattern and glycemic alterations: does post-prandial glucose rise predict lack of nocturnal pressure drop? 49
Endogenous PCSK9 may influence circulating CD45neg/CD34bright and CD45neg/CD34bright/CD146neg cells in patients with type 2 diabetes mellitus 46
null 41
Hunting for a coronary artery disease diagnosis in asymptomatic patients with diabetes mellitus: if, how and when 4
Circulating S100A8/A9 drives faster platelet COX-1 recovery via MRP4, impairing the duration of aspirin response 4
Significance of 8-iso-PGF2α in cardiovascular diseases 1
Totale 4.452
Categoria #
all - tutte 19.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022204 5 5 1 20 6 26 18 14 32 12 13 52
2022/2023581 37 83 31 52 63 106 29 58 70 6 27 19
2023/2024428 29 3 35 9 22 127 58 57 13 25 9 41
2024/2025694 45 106 78 14 26 52 60 55 56 46 91 65
2025/20261.982 152 86 237 220 191 110 323 104 205 199 76 79
Totale 4.452